Navigation Links
No Place Safe From Allergies
Date:9/5/2008

le life without limits wherever you go."

The important thing is to find out what triggers your allergies, Waldron said. Allergies can be exacerbated by things encountered outside such as pollen, but there are also indoor triggers such as pet dander and dust mites.

The report was paid for by McNEIL-PPC Inc., maker of the allergy drug Zyrtec.

More information

For more about allergies, visit the U.S. National Library of Medicine.



--Steve Reinberg



SOURCES: Angel Waldron, spokeswoman, Asthma and Allergy Foundation of America; Sept. 8, 2008, 2008 Fall Allergy Capitals


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Z Trim Holdings, Inc. Announces Private Placement Funding
2. Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke
3. Afid Therapeutics Inc.s New Anticoagulant Heparin Replacement Passes in Vivo Test
4. Lumension Security Launches Interactive Office Game To Educate IT Professionals On 10 Most Common Security Risks Within The Workplace
5. Will Lumineers Replace Traditional Veneers?
6. AARP the Magazine Names the Top 10 Healthiest Places to Live in America
7. Stopping Smoking in the Workplace Continues to Be a Challenge
8. Qtrac Software and Patient Placement Systems Announce Partnership and Healthcare Data Interface
9. Employers Take Active Role in Promoting Workplace Wellness
10. Kroll Fraud Solutions Launches "Handling Sensitive Patient Information in the Healthcare Workplace: An eLearning Course for Safeguarding Patient Data"
11. Hormone Replacement May Raise Womens Gallbladder Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
No Place Safe From Allergies
No Place Safe From Allergies
(Date:1/8/2009)...Newswire-USNewswire/ -- The Pew Charitable Trusts ...director, chemical and food safety programs, in it...n, who was formerly deputy staff director and gene... and Public Works, brings nearly 25 years of exper...y to Pew. , , "We are excited to be joined by ...
(Date:1/8/2009)...RNewswire-FirstCall/ -- Cephalon, Inc . (Nasdaq: ...Ph.D., Chairman and CEO will present at the J.P. ...y 13, 2009 in San Francisco, CA at approximately 4...resentation will be webcast live on the investor r... The webcast will be archived for one week followi...
(Date:1/8/2009)...8 Heska Corporation (Nas... , , What: Heska Corporation Invites You...r-End 2008 Earnings Conference Call on the Web,...MST], Where: www.heska.com (click on the ...link on the front page of this website)., Ho...
(Date:1/8/2009)...n. 8 St. Jude Children,s Research,...d that FedExCup Runner-Up,Camilo Villegas has inc...a,pledge to match Singh,s donation of $5,000 to S...TOUR. Eagles for St. Jude is a powerful program t...Singh and rising LPGA star Morgan,Pressel, along ...
Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...y conducted by the Mayo Clinic has revealed that a... Fibromyalgia is a disorder considered disabling ...ad musculoskeletal pain and symptoms such as fatig...ep disturbance. No cure is known and available tre...
...y has shown that reality was different from severa...pular misconception among both the young// and the...ccur when they're young in spite of research havin...equated with unhappiness for other people, individ...
...the study conducted by the Public Service Commissi...er of public servants believe HIV/AIDS is curable/... ere surveyed fall in to the category of very high...ey are measured on a scale from one to five, with ...
...the Malaysian Health Minister Chua Soi Lek the peo...sary. Hence he requested the people to cut down// ...tyle. According to the statistics Malaysians on an...veryday. This is extremely high as the health off...
Other Medicine News:Health News:Acupuncture to Relieve Fibromyalgia Symptoms 2Health News:Attitudes About Aging Different from Reality 2Health News:Attitudes About Aging Different from Reality 3
(Date:1/7/2009)...ase , , WHITE PLAINS, N.Y., Jan. 7 /PRNewswire-...hat the decades-long rise in the United States pre...an ever at increased risk of death and disability ...,000 babies were born too soon in 2006, according ...h today released "Births: Final data for 2006," Na...
(Date:1/6/2009)...s from prior U.S., U.K. and China Trials , , SA...nc. (VTI), a development stage company targeting l...as begun for a randomized, controlled, multi-cente...acorporeal Liver Assist Device (ELAD) as a treatme...er three protocols. The study is open for enrollme...
(Date:1/6/2009).../ -- Cequent Pharmaceuticals, a pioneer in the dev...reatments to prevent and treat human disease, anno...ccessful toxicology study of its candidate CEQ501,...ting the primary oncogene (beta-catenin, CTNNB1) i...inherited gastrointestinal disease that causes hun...
(Date:1/5/2009)...wire/ -- Women undergoing in vitro,fertilization ...ort early,pregnancy, but the intramuscular inject...nful for patients. Formulations of progesterone m...us injection or vaginal suppository may offer,sim... With patient well-being a constant focus, Ferti...
Breaking Medicine Technology:Preterm Births Rise 36 Percent Since Early 1980s 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2UT Southwestern researchers create molecule that nudges nerve stem cells to mature 3639 1UT Southwestern researchers create molecule that nudges nerve stem cells to mature 3639 2UT Southwestern researchers create molecule that nudges nerve stem cells to mature 3639 3A Health Gift for Men on Fathers Day 21866 1A Health Gift for Men on Fathers Day 21866 2Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 1Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 2Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 3Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 4Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 5Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 6Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 7Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 8Soliris 28R 29 Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis 2427 9Novel model of osteosarcoma 21861 1
...SBAD, CA, May 31, 2007 /PRNewswire-FirstCall/,- On..., Inc. today,announced that preliminary data from ...ted at the American Society of Clinical,Oncology A...ata,from a Phase II clinical study of OGX-011 in h...Phase I/II clinical study of,OGX-011 in non-small ...
...y of Gene Therapy in Lipoprotein Lipase,Deficiency..., 2007 - Amsterdam Molecular,Therapeutics (AMT), a...ed positive Phase I/II clinical trial results with...011) in Complete,Lipoprotein Lipase (LPL) deficien...can Society of Gene Therapy (ASGT) in Seattle.,The...
Other Medicine Technology:OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: